TOCQUEVILLE ASSET MANAGEMENT L.P.

Position in CGTX — Cognition Therapeutics Inc

CIK 883961 New York, NY

Position in CGTX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$368,575

+$220,375 QoQ

Shares Held

320,500

+64.4% QoQ

Ownership

0.337%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#14

of 66 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TOCQUEVILLE ASSET MANAGEMENT L.P. holds $29,586,127 across 12 Biotechnology names. CGTX ranks #9 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	251,215	$19,918,837
2	REGN	Regeneron Pharmaceuticals, Inc.	3,315	$2,067,035
3	CSBR	Champions Oncology, Inc.	295,658	$1,821,253
4	BBIO	BridgeBio Pharma, Inc.	19,650	$1,463,532
5	MGTX	MeiraGTx Holdings plc	77,700	$1,049,727
6	RARE	Ultragenyx Pharmaceutical Inc.	31,250	$1,043,437
7	IMMX	Immix Biopharma, Inc.	88,550	$912,950
8	AXSM	Axsome Therapeutics, Inc.	2,300	$562,971

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$368,575	320,500	+64.4%	Shares	Sole	2026-08-10
2026-03-31	$148,200	195,000	+1.3%	Shares	Sole	2026-05-12
2025-12-31	$259,875	192,500	+18.5%	Shares	Sole	2026-02-12
2025-09-30	$219,375	162,500	+470.2%	Shares	Sole	2025-11-13
2025-06-30	$8,835	28,500	0.0%	Shares	Sole	2025-08-12
2025-03-31	$11,998	28,500	0.0%	Shares	Sole	2025-05-13
2024-12-31	$19,978	28,500	+21.3%	Shares	Sole	2025-02-10
2024-09-30	$11,021	23,500	-41.2%	Shares	Sole	2024-11-08
2024-06-30	$66,400	40,000	+53.8%	Shares	Sole	2024-08-12
2024-03-31	$47,320	26,000	—	Shares	Sole	2024-05-09
No filing history on record for this holder in this stock.